BioNTech SE exceeded earnings expectations with strong oncology pipeline development, despite reduced vaccine revenue.

A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in funding from the United States government. As a result, several promising ...

Everest Medicines' stock (1952.HK) surged today, opening higher and maintaining strong momentum throughout the trading day. By market close, the stock had risen 20.12% to HK$60.6, bringing the company ...

Republicans have proposed legislation in several states to ban the pioneering technology used in covid shots. Many doctors ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Moderna (NasdaqGS:MRNA) recently faced significant legal challenges with five international lawsuits from Genevant Sciences and Arbutus Biopharma targeting its LNP technology used in products like ...

Sky-high egg prices have drawn renewed attention to the bird flu outbreak, which has caused more than 166 million wild and ...

Indeed, record-breaking vaccine development played a big role in keeping the SARS-CoV-2 virus at bay. Vaccine skeptics have ...

The Florida surgeon general in January called for a halt in the use of covid mRNA vaccines. And in Texas, Attorney General ...

AstraZeneca is withdrawing its corona vaccine Vaxzevria worldwide.

Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...

Moderna shares experienced a significant surge in trading on Thursday, posting a 5.58% gain in European markets and an impressive jump of up to 16% on the NASDAQ. This remarkable performance was ...